Literature DB >> 32827646

The role of synaptic microRNAs in Alzheimer's disease.

Subodh Kumar1, P Hemachandra Reddy2.   

Abstract

Structurally and functionally active synapses are essential for neurotransmission and for maintaining normal synaptic and cognitive functions. Researchers have found that synaptic dysfunction is associated with the onset and progression of neurodegenerative diseases, such as Alzheimer's disease (AD), and synaptic dysfunction is even one of the main physiological hallmarks of AD. MiRNAs are present in small, subcellular compartments of the neuron such as neural dendrites, synaptic vesicles, and synaptosomes are known as synaptic miRNAs. Synaptic miRNAs involved in governing multiple synaptic functions that lead to healthy brain functioning and synaptic activity. However, the precise role of synaptic miRNAs has not been determined in AD progression. This review emphasizes the presence of miRNAs at the synapse, synaptic compartments and roles of miRNAs in multiple synaptic functions. We focused on synaptic miRNAs alteration in AD, and how the modulation of miRNAs effect the synaptic functions in AD. We also discussed the impact of synaptic miRNAs in AD progression concerning the synaptic ATP production, mitochondrial function, and synaptic activity.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; MicroRNAs; Synapse; Synaptic activity; Synaptosome

Mesh:

Substances:

Year:  2020        PMID: 32827646      PMCID: PMC7680400          DOI: 10.1016/j.bbadis.2020.165937

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  107 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  MicroRNA abundance is altered in synaptoneurosomes during prion disease.

Authors:  Amrit S Boese; Reuben Saba; Kristyn Campbell; Anna Majer; Sarah Medina; Lynn Burton; Timothy F Booth; Patrick Chong; Garrett Westmacott; Sucharita M Dutta; Julian A Saba; Stephanie A Booth
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

3.  Synaptosomes secrete and uptake functionally active microRNAs via exocytosis and endocytosis pathways.

Authors:  Jie Xu; Qun Chen; Ke Zen; Chenyu Zhang; Qipeng Zhang
Journal:  J Neurochem       Date:  2012-11-21       Impact factor: 5.372

Review 4.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

Review 5.  Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2016-06-02

6.  A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease.

Authors:  Xiong Wang; Dan Liu; He-Zhou Huang; Zhi-Hao Wang; Tong-Yao Hou; Xin Yang; Pei Pang; Na Wei; Ya-Fan Zhou; Marie-Josée Dupras; Frédéric Calon; Yu-Tian Wang; Heng-Ye Man; Jian-Guo Chen; Jian-Zhi Wang; Sébastien S Hébert; Youming Lu; Ling-Qiang Zhu
Journal:  Biol Psychiatry       Date:  2017-08-10       Impact factor: 13.382

7.  MicroRNA-9 controls dendritic development by targeting REST.

Authors:  Sebastian A Giusti; Annette M Vogl; Marisa M Brockmann; Claudia A Vercelli; Martin L Rein; Dietrich Trümbach; Wolfgang Wurst; Demian Cazalla; Valentin Stein; Jan M Deussing; Damian Refojo
Journal:  Elife       Date:  2014-11-18       Impact factor: 8.140

8.  Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.

Authors:  Dolores Siedlecki-Wullich; Judit Català-Solsona; Cristina Fábregas; Isabel Hernández; Jordi Clarimon; Alberto Lleó; Merce Boada; Carlos A Saura; José Rodríguez-Álvarez; Alfredo J Miñano-Molina
Journal:  Alzheimers Res Ther       Date:  2019-05-15       Impact factor: 6.982

9.  miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q.

Authors:  Nan Xu; Ang-Di Li; Li-Li Ji; Yao Ye; Zhen-Yu Wang; Lei Tong
Journal:  Eur J Histochem       Date:  2019-05-03       Impact factor: 3.188

10.  MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion.

Authors:  Mei-Ling Yan; Shuai Zhang; Hong-Mei Zhao; Sheng-Nan Xia; Zhuo Jin; Yi Xu; Lin Yang; Yang Qu; Si-Yu Huang; Ming-Jing Duan; Meng Mao; Xiao-Bin An; Chandan Mishra; Xin-Yu Zhang; Li-Hua Sun; Jing Ai
Journal:  Cell Commun Signal       Date:  2020-04-06       Impact factor: 5.712

View more
  8 in total

Review 1.  Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.

Authors:  Prashanth Gowda; P Hemachandra Reddy; Subodh Kumar
Journal:  Ageing Res Rev       Date:  2021-11-20       Impact factor: 10.895

2.  MeCP2 loss-of-function dysregulates microRNAs regionally and disrupts excitatory/inhibitory synaptic transmission balance.

Authors:  Patricia M Horvath; Michelle K Piazza; Ege T Kavalali; Lisa M Monteggia
Journal:  Hippocampus       Date:  2022-07-19       Impact factor: 3.753

3.  Elevated levels of MicroRNA-455-3p in the cerebrospinal fluid of Alzheimer's patients: A potential biomarker for Alzheimer's disease.

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-05       Impact factor: 5.187

4.  RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease.

Authors:  Sanjay Awasthi; Ashly Hindle; Neha A Sawant; Mathew George; Murali Vijayan; Sudhir Kshirsagar; Hallie Morton; Lloyd E Bunquin; Philip T Palade; J Josh Lawrence; Hafiz Khan; Chhanda Bose; P Hemachandra Reddy; Sharda P Singh
Journal:  Cells       Date:  2021-11-10       Impact factor: 6.600

Review 5.  A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders.

Authors:  Maddie Perdoncin; Alec Konrad; Joshua R Wyner; Samir Lohana; Sneha S Pillai; Duane G Pereira; Hari Vishal Lakhani; Komal Sodhi
Journal:  Front Mol Neurosci       Date:  2021-10-07       Impact factor: 6.261

6.  Synaptosome microRNAs regulate synapse functions in Alzheimer's disease.

Authors:  Subodh Kumar; Erika Orlov; Prashanth Gowda; Chhanda Bose; Russell H Swerdlow; Debomoy K Lahiri; P Hemachandra Reddy
Journal:  NPJ Genom Med       Date:  2022-08-08       Impact factor: 6.083

7.  Plasma microRNAs as potential biomarkers in early Alzheimer disease expression.

Authors:  Carmen Peña-Bautista; Adrián Tarazona-Sánchez; Aitana Braza-Boils; Angel Balaguer; Laura Ferré-González; Antonio J Cañada-Martínez; Miguel Baquero; Consuelo Cháfer-Pericás
Journal:  Sci Rep       Date:  2022-09-16       Impact factor: 4.996

Review 8.  microRNA-Based Biomarkers in Alzheimer's Disease (AD).

Authors:  Yuhai Zhao; Vivian Jaber; Peter N Alexandrov; Andrea Vergallo; Simone Lista; Harald Hampel; Walter J Lukiw
Journal:  Front Neurosci       Date:  2020-10-30       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.